Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors (Q3300940): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in fr, el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, de, it, es, and other parts: Adding translations: el, nl, en, da, fi, mt, it, lv, fr, es, sk, ga, cs, pt, de, et, hu, bg, lt, hr, sv, ro, sl, pl,) |
(BatchIngestion) |
||
Property / contained in Local Administrative Unit | |||
Property / contained in Local Administrative Unit: Hennigsdorf, Stadt / rank | |||
Normal rank |
Revision as of 18:46, 9 June 2023
Project Q3300940 in Germany
Language | Label | Description | Also known as |
---|---|---|---|
English | Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors |
Project Q3300940 in Germany |
Statements
327,791.28 Euro
0 references
409,739.1 Euro
0 references
80.0 percent
0 references
1 October 2020
0 references
30 September 2022
0 references
AmpliVak Immunotherapy GmbH
0 references
Hennigsdorf, Stadt
0 references
Identifiers
DE_TEMPORARY_3742
0 references